ABN Amro has received a 'buy' recommendation from UBS, with a revised price target of €18.1, down from €19.5. This suggests a potential upside of 17% for the stock.
UBS expects double-digit earnings per share revisions for 2025 and beyond, citing factors such as lower interest rates, increased costs, and issues with Additional Tier 1 (AT1) capital instruments.
Investors should take these factors into consideration when assessing the financial institution's performance updates.